US-based pharmaceutical company Pfizer invested EUR 150 Million in a new Plant in Strängnäs, Stockholm. The Swedish capital region is expected to strengthen its position, attracting investment in the life sciences industry and the most prominent researchers.
At least EUR 5 billion will be invested in the life sciences sector in the Karolinska-Norra Station district, Stockholm, until 2025, which makes it the largest investment ever in Sweden.
Link to this comment:
All Comments (0)